Liposomal Cytokines and Liposomes Targeted to Co-Stimulatory Molecules as Adjuvants for HIV Subunit Vaccines

Vaccine Adjuvants and Delivery Systems

Volumn , Issue , 2006, Pages 249-261

  Ozpolat, Bulent ^a   Lachman, Lawrence B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Immunoliposomes binding target cells expressing co stimulatory molecules; Liposomal cytokines and liposomes targeted; Liposome vaccine platform and subunit vaccines

Indexed keywords

EID: 84889462051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470134931.ch11     Document Type: Chapter

References (20)

1. Allison, A.G. & Gregoriadis, G. Liposomes as immunological adjuvants. Nature 1974, 252(5480), 252.
2. Ozpolat, B., Rao, X.M., Powell, M.F. & Lachman, L.B. Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines. AIDS Res Hum Retroviruses 1998, 14(5), 409-417.
3. Moser, C., Metcalfe, I.C. & Viret, J.F. Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2003, 2(2), 189-196.
4. Fries, L.F., Montemarano, A.D., Mallett, C.P., Taylor, D.N., Hale, T.L. & Lowell, G. H. Safety and immunogenicity of a proteosome-Shigella fl exneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infect Immun 2001, 69(7), 4545-4553.
5. Patel, G.B., Zhou, H., KuoLee, R. & Chen, W. Archaeosomes as adjuvants for combination vaccines. J Liposome Res 2004, 14(3-4), 191-202.
6. Allison, A.C. & Byars, N.E. Immunological adjuvants and their mode of action. Biotechnology 1992, 20, 431-449.
7. Bhardwaj, N. Processing and presentation of antigens by dendritic cells: implications for vaccines. Trends Mol Med 2001, 7(9), 388-394.
8. Mosmann, T.R. Tlymphocyte subsets, cytokines, and effector functions. Ann NY Acad Sci 1992, 664, 89-92.
9. Sprent, J. Antigen-presenting cells: professionals and amateurs. Curr Biol 1995, 5(10), 1095-1097.
10. Bluestone, J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995, 2(6), 555-559.
11. Chambers, M.A., Vordermeier, H., Whelan, A. et al. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83. Clin Infect Dis 2000, 30(Suppl 3), S283-287.
12. Linsley, P.S., Greene, J.L., Tan, P. et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992, 176(6), 1595-1604.
13. Krummel, M.F. & Allison, J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995, 182(2), 459-465.
14. Magott-Procelewska, M. Costimulatory pathways as a basic mechanisms of activating a tolerance signal in T cells. Ann Transplant 2004, 9(3), 13-18.
15. Heath, A.W. & Playfair, J.H. The potential of cytokines as adjuvants. AIDS Res Hum Retroviruses 1992, 8(8), 1401-1403.
16. Lachman, L.B., Ozpolat, B. & Rao, X.M. Cytokine-containing liposomes as vaccine adjuvants. Eur Cytokine Netw 1996, 7(4), 693-698.
17. Gregoriadis, G. The immunological adjuvant and vaccine carrier properties of liposomes. J Drug Target 1994, 2(5), 351-356.
18. Phillips, N.C. & Dahman, J. Immunogenicity of immunoliposomes: reactivity against species-specifi c IgG and liposomal phospholipids. Immunol Lett 1995, 45(3), 149-152.
19. Gregoriadis, G., Davis, D. & Davies, A. Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine 1987, 5(2), 145-151.
20. Lachman, L.B., Shih, L.C., Rao, X.M. et al. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines. AIDS Res Hum Retroviruses 1995, 11(8), 921-932.